Tonix Pharmaceuticals Holding Share Price Today
(NASDAQ: TNXP)

Name: Tonix Pharmaceuticals Holding Share Price Today (NASDAQ: TNXP) - Tonix Pharmaceuticals Holding Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Tonix Pharmaceuticals Holding share price is $17.19 & ₹1,466.69 as on 25 Apr 2025, 2.30 'hrs' IST

$17.19

▲

0.17

(1%)

Market is closed - opens 7 PM, 25 Apr 2025

View live Tonix Pharmaceuticals Holding share price in Dollar and Rupees. Guide to invest in Tonix Pharmaceuticals Holding stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Tonix Pharmaceuticals Holding, along with analyst recommendations, forecasts, and comprehensive financials.

Tonix Pharmaceuticals Holding share price movements

Today's Low: $16.84
Today's High: $18.44
$17.19
2.04%
Downside
Day's Volatility :8.7%
Upside
6.8%
52 Weeks Low: $6.76
52 Weeks High: $672.00
$17.19
60.67%
Downside
52 Weeks Volatility :98.99%
Upside
97.44%

Tonix Pharmaceuticals Holding (TNXP) Returns

Period	Tonix Pharmaceuticals Holding Corp.	Sector (Health Care)	Index (Russel 2000)
3 Months	-55.48%	-6.0%	0.0%
6 Months	3.05%	-9.2%	0.0%
1 Year	-96.67%	-3.7%	0.0%
3 Years	-99.98%	1.5%	-8.8%

Tonix Pharmaceuticals Holding (TNXP) Key Statistics

in dollars & INR

Previous Close	$17.02
Open	$17.57
Today's High	$18.4448
Today's Low	$16.84
Market Capitalization	$108.1M
Today's Volume	$848.9K
52 Week High	$672.0
52 Week Low	$6.76
Revenue TTM	$10.1M
EBITDA	$-74.3M
Earnings Per Share (EPS)	$-176.6
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-106.12%

How to invest in Tonix Pharmaceuticals Holding Stock (TNXP) from India?

It is very easy for Indian residents to invest directly in Tonix Pharmaceuticals Holding from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Tonix Pharmaceuticals Holding stock in both Indian Rupees (INR) and US Dollars (USD). Search for Tonix Pharmaceuticals Holding or TNXP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Tonix Pharmaceuticals Holding or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Tonix Pharmaceuticals Holding shares which would translate to 0.050 fractional shares of Tonix Pharmaceuticals Holding as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Tonix Pharmaceuticals Holding, in just a few clicks!

Returns in Tonix Pharmaceuticals Holding (TNXP) for Indian investors in Rupees

The Tonix Pharmaceuticals Holding stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Tonix Pharmaceuticals Holding investment value today

Current value as on today

₹5,754

Returns

₹94,246

(-94.25%)

Returns from Tonix Pharmaceuticals Holding Stock

₹96,643 (-96.64%)

Dollar Returns

₹2,397 (+2.4%)

Indian investors sentiment towards Tonix Pharmaceuticals Holding (TNXP)

-34.7%

Period: Mar 25, 2025 to Apr 24, 2025. Change in 30 Days versus previous period

Investment in Tonix Pharmaceuticals Holding Shares from India has dropped by -34.7% over the past 30 days, indicating reduced transactional activity.

Period: Mar 25, 2025 to Apr 24, 2025. Change in 30 Days versus previous period

Search interest for Tonix Pharmaceuticals Holding Stock from India on INDmoney has increased by 4% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Tonix Pharmaceuticals Holding

BlackRock Inc
0.92%
Geode Capital Management, LLC
0.31%
UBS Group AG
0.28%
Jane Street Group LLC
0.26%
Rhumbline Advisers
0.21%
Northern Trust Corp
0.08%

Analyst Recommendation on Tonix Pharmaceuticals Holding

Rating

Trend

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Tonix Pharmaceuticals Holding(by analysts ranked 0 to 5 stars)

Analyst Forecast on Tonix Pharmaceuticals Holding Stock (TNXP)

What analysts predicted

Upside of 249.04%

Target:

$60.00

Current:

$17.19

Insights on Tonix Pharmaceuticals Holding Stock (Ticker Symbol: TNXP)

Price Movement
In the last 1 month, TNXP stock has moved down by -44.1%
Decreasing Revenue
Revenue is down for the last 2 quarters, 2.82M → 2.58M (in $), with an average decrease of 8.5% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -14.21M → -22.10M (in $), with an average decrease of 55.6% per quarter
TNXP vs ONC (1 yr)
In the last 1 year, Beone Medicines Ltd has given 73.9% return, outperforming this stock by 170.6%
TNXP vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 53.1% return, outperforming this stock by 153.1%
Price to Sales
ForTNXP every $1 of sales, investors are willing to pay $1.3, whereas for Beone Medicines Ltd, the investors are paying $7.1 for every $1 of sales.

Tonix Pharmaceuticals Holding Technicals Summary

Sell

Neutral

Buy

Tonix Pharmaceuticals Holding is currently in a neutral trading position according to technical analysis indicators.

Tonix Pharmaceuticals Holding (TNXP) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Tonix Pharmaceuticals Holding Corp.	-42.71%	3.05%	-96.67%	-99.98%	-100.0%
Regeneron Pharmaceuticals, Inc.	-8.15%	-36.99%	-33.99%	-12.87%	7.38%
Beone Medicines Ltd	-0.1%	17.79%	68.73%	64.3%	51.92%
Vertex Pharmaceuticals Incorporated	-1.59%	3.06%	23.79%	83.91%	83.35%
Alnylam Pharmaceuticals, Inc.	-9.98%	-14.92%	68.63%	56.35%	69.83%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Tonix Pharmaceuticals Holding Corp.	NA	NA	0.0	-11.89	-1.06	-0.31	NA	31.82
Regeneron Pharmaceuticals, Inc.	15.27	15.27	0.93	40.58	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.09	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	17.95	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.72	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Tonix Pharmaceuticals Holding Corp.	Buy	$108.1M	-100.0%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$62.9B	7.38%	15.27	31.07%
Beone Medicines Ltd	NA	$28.7B	51.92%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$126.1B	83.35%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$30.6B	69.83%	NA	-12.37%

About Tonix Pharmaceuticals Holding

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease. It markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. Its portfolio focuses on central nervous system disorders, as well as immunology, infectious disease, and rare disease product candidates. The company's products pipeline include TNX-102 SL (cyclobenzaprine HCl sublingual tablet), for the management of fibromyalgia; and is being developed to prevent and treat acute stress reaction, posttraumatic stress disorder, Alzheimer's disease, alcohol use disorder, and multi-site pain associated with Long COVID. It also develops TNX-1300, a double-mutant cocaine esterase, which is in Phase 2 clinical trials for the treatment of cocaine intoxication; and TNX-1900, an intranasal potentiated oxytocin for the treatment of binge eating disorder, adolescent obesity, and bone health in pediatric autism, as well as for social anxiety disorder. In addition, the company develops TNX-1500, an Fc-modified humanized monoclonal antibody indicated to prevent organ transplant rejection, as well as to treat autoimmune conditions; TNX-1700, a recombinant Trefoil Factor Family 2 fusion protein for the treatment of gastric and colorectal cancers; TNX-801 that is in the pre-IND development stage for protection against smallpox and mpox; and TNX-1800, a live virus vaccine for SARS-CoV-2. Its rare disease portfolio consists of TNX-2900, an intranasal potentiated oxytocin to treat for Prader-Willi syndrome. The company has collaboration agreement with Bilthoven Biologicals to advance TNX-801 and Makana Therapeutics, Inc. to study TNX-1500 for human-compatible organs and cells for the treatment of organ failure. Tonix Pharmaceuticals Holding Corp. is headquartered in Chatham, New Jersey.

Organization	Tonix Pharmaceuticals Holding
Employees	81
CEO	Dr. Seth Lederman M.D.
Industry	Health Technology

Management People of Tonix Pharmaceuticals Holding

Name	Title
Dr. Seth Lederman M.D.	Co-Founder, President, CEO & Chairman
Mr. Bradley Saenger CPA	CFO & Treasurer
Mrs. Jessica Edgar Morris	Chief Operating Officer
Dr. Gregory M. Sullivan M.D.	Chief Medical Officer & Secretary
Ms. Siobhan Fogarty B.Sc., M.Sc.	Chief Technical Officer
Dr. Darryl Rideout Ph.D.	Executive Vice President of Experimental Chemistry
Dr. Sina Bavari Ph.D.	Executive Vice President of Infectious Disease Research & Development
Dr. Zeil Rosenberg M.D., M.P.H.	Executive Vice President of Medical
Mr. Thomas Englese M.B.A.	Executive Vice President of Commercial Operations

Important FAQs about investing in TNXP Stock from India :

What is Tonix Pharmaceuticals Holding share price today?

Tonix Pharmaceuticals Holding share price today stands at $17.19, Open: $17.57 ; Previous Close: $17.02 ; High: $18.44 ; Low: $16.84 ; 52 Week High: $672.00 ; 52 Week Low: $6.76.

The stock opens at $17.57, after a previous close of $17.02. The stock reached a daily high of $18.44 and a low of $16.84, with a 52-week high of $672.00 and a 52-week low of $6.76.

Can Indians buy Tonix Pharmaceuticals Holding shares?

Yes, Indians can invest in the Tonix Pharmaceuticals Holding (TNXP) from India.

With INDmoney, you can buy Tonix Pharmaceuticals Holding at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Tonix Pharmaceuticals Holding at zero transaction cost.

How can I buy Tonix Pharmaceuticals Holding shares from India?

It is very easy to buy Tonix Pharmaceuticals Holding from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Tonix Pharmaceuticals Holding (TNXP) be purchased?

Yes, you can buy fractional shares of Tonix Pharmaceuticals Holding with INDmoney app.

What are the documents required to start investing in Tonix Pharmaceuticals Holding stocks?

To start investing in Tonix Pharmaceuticals Holding, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.